Loading quotes...
Forecast
The analysts' average price target is €6.36 (+42.92%). The median is €6.36 (+42.92%).
| Buy |
1 |
| Hold |
2 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
LifeVantage misses Q4 forecasts — revenue falls sharply, shares tumble
LifeVantage reported a 23.1% decline in Q4 revenue to $42.4 million and adjusted EPS of $0.11 (expectation $0.13). The stock fell in regular trading and slipped further after hours after revenue and earnings came in below estimates. New CEO Terrence Moorehead announced a turnaround plan focused on branding, digital strategy and customer retention; no formal guidance was given for 2027. » More on de.investing.com
Lifevantage to release quarterly results for period ended June 30, 2026, on August 27, 2026
Lifevantage will present results for the quarter ended June 30, 2026, on August 27, 2026. Two analysts expect on average earnings of $0.115 per share versus $0.150 in the year-ago quarter and revenue of about $44.0 million (‑20.2% versus $55.1 million). For the past fiscal year estimates are $0.560 earnings per share and $184.2 million in revenue, after $0.750 and $228.5 million in the prior year. » More on finanzen.net
LifeVantage declares quarterly cash dividend of $0.05
The board of directors of LifeVantage has declared a quarterly cash dividend of $0.05 per common share. Payment will be made on September 15, 2026 to shareholders of record at the close of business on September 1, 2026. The company sells health and wellness products through independent consultants. » More on de.investing.com
LifeVantage appoints Terrence Moorehead as CEO
LifeVantage announces the appointment of Terrence Moorehead as president and chief executive officer and as a member of the board of directors effective August 5, 2026. The change follows a 68.6% drop in the share price over the past year; the stock is at $4.57 and market capitalization is $58.4 million. Steve Fife will resign on April 30, 2026; Michael Beindorff will serve as interim CEO until Moorehead assumes his duties after fulfilling contractual obligations with his previous employer. Moorehead was previously CEO of Nature’s Sunshine, where he increased revenue by 45% and EBITDA by 190%; valuation metrics suggest potential undervaluation (P/E 7.43, gross margin 78.75%). » More on de.investing.com
LifeVantage plans to enter Portuguese market in May 2026
LifeVantage announced it will introduce its products and direct-selling model with independent consultants in Portugal in May 2026. At launch it will offer Protandim Nrf2 Synergizer, Protandim Nrf1 Synergizer and TrueScience Liquid Collagen, as well as product bundles such as Healthy Glow Essentials. The market entry will use the “Evolve” compensation plan; the company plans to roll out additional products gradually. LifeVantage said the expansion supports international growth, while revenue has recently declined slightly and the stock fell sharply last year, although the company maintains a high gross margin. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 32.77m | 19.15% |
| Gross profit | 24.69m | 23.37% |
| Net profit | -173.04k | 109.42% |
| EBITDA | 482.04k | 80.16% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €57.25m |
Number of shares | 12.68m |
52-week high/low | €10.64 - €3.54 |
Dividend yield | 3.63% |
Dividends TTM | €0.16 |
Next dividend | €0.0454 |
Beta | 0.74 |
P/E ratio | 23.19 |
PEG ratio | -0.31 |
P/B ratio | 1.86 |
P/S ratio | 0.37 |
Company profile
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
| Name | Lifevantage Co. |
| CEO | Terrence Moorehead |
| Headquarters | Lehi,
ut USA |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 07/04/1994 |
| Employees | 216 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | LFVN |
Frankfurt | L2T1.F |